Jamie Goldman

Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study

Jonathan Strosberg, Al B. Benson, Lynn Huynh et al. · The Oncologist · 2014 · 110 citations · Full text

Medicine, Endocrinology, Oncology +17

Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

Dylan J. Martini, Subir Goyal, Yuan Liu et al. · The Oncologist · 2021 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

Dylan J. Martini, T. Anders Olsen, Subir Goyal et al. · Frontiers in Oncology · 2021 · 36 citations · Full text

Medicine, Oncology, Radiology +17

Above-Label Doses of Octreotide-LAR in Patients With Metastatic Small Intestinal Carcinoid Tumors.

Jonathan Strosberg, Jill Weber, Max Feldman et al. · PubMed · 2013 · 36 citations

Medicine, Oncology, Pharmacology +14

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

Dylan J. Martini, Julie M. Shabto, Subir Goyal et al. · The Oncologist · 2021 · 32 citations · Full text

Medicine, Immunology, Oncology +17